Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.

Schlesinger T, Chapman MS, Tu JH, Cohen JL, Strasswimmer J, Zeitouni NC, Torres A, Jazayeri SS, Goldman MP, Ibrahim SF, Lain EL, Couvillion MP, Bruce S, Laquer VT, Hanke CW, Ozog DM, Schneider J, Markowitz O, Berman B, Nestor MS, Gold MH, Munavalli GS, Forsha DW, Siegel DM, Mrohs D, Schmitz B, Schäning R, Pospiech N, Lyons J, Foguet M, Lübbert M, Lübbert H, Pariser DM

Open source

DOI
10.1016/j.jaad.2025.08.031
Published
2025 Dec
Container
Journal of the American Academy of Dermatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaad.2025.08.031,
  title = {Red light photodynamic therapy with 10\% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.},
  author = {Schlesinger T and Chapman MS and Tu JH and Cohen JL and Strasswimmer J and Zeitouni NC and Torres A and Jazayeri SS and Goldman MP and Ibrahim SF and Lain EL and Couvillion MP and Bruce S and Laquer VT and Hanke CW and Ozog DM and Schneider J and Markowitz O and Berman B and Nestor MS and Gold MH and Munavalli GS and Forsha DW and Siegel DM and Mrohs D and Schmitz B and Schäning R and Pospiech N and Lyons J and Foguet M and Lübbert M and Lübbert H and Pariser DM},
  year = {2025},
  journal = {Journal of the American Academy of Dermatology},
  doi = {10.1016/j.jaad.2025.08.031},
  url = {https://doi.org/10.1016/j.jaad.2025.08.031}
}

RIS

TY  - JOUR
TI  - Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.
AU  - Schlesinger T
AU  - Chapman MS
AU  - Tu JH
AU  - Cohen JL
AU  - Strasswimmer J
AU  - Zeitouni NC
AU  - Torres A
AU  - Jazayeri SS
AU  - Goldman MP
AU  - Ibrahim SF
AU  - Lain EL
AU  - Couvillion MP
AU  - Bruce S
AU  - Laquer VT
AU  - Hanke CW
AU  - Ozog DM
AU  - Schneider J
AU  - Markowitz O
AU  - Berman B
AU  - Nestor MS
AU  - Gold MH
AU  - Munavalli GS
AU  - Forsha DW
AU  - Siegel DM
AU  - Mrohs D
AU  - Schmitz B
AU  - Schäning R
AU  - Pospiech N
AU  - Lyons J
AU  - Foguet M
AU  - Lübbert M
AU  - Lübbert H
AU  - Pariser DM
PY  - 2025
JO  - Journal of the American Academy of Dermatology
DO  - 10.1016/j.jaad.2025.08.031
UR  - https://doi.org/10.1016/j.jaad.2025.08.031
ER  - 

APA

T, S., MS, C., JH, T., JL, C., J, S., NC, Z., A, T., SS, J., MP, G., SF, I., EL, L., MP, C., S, B., VT, L., CW, H., DM, O., J, S., O, M., B, B., MS, N., MH, G., GS, M., DW, F., DM, S., D, M., B, S., R, S., N, P., J, L., M, F., M, L., H, L., & DM, P. (2025). Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2025.08.031

Source records